TCM
Tang Capital Management Portfolio holdings
AUM
$2.02B
1-Year Est. Return
102.23%
This Fund
S&P 500
1 Year Est. Return
+102.23%
AUM
$2.02B
AUM Growth
-$573M
(-22%)
Holding
201
Top Buys
| 1 | +$58.1M | |
| 2 | +$22.2M | |
| 3 | +$20.3M | |
| 4 |
BioNTech
BNTX
|
+$20.1M |
| 5 |
ANI Pharmaceuticals
ANIP
|
+$14.2M |
Top Sells
| 1 | +$94.5M | |
| 2 | +$56.5M | |
| 3 | +$42.1M | |
| 4 |
Vera Therapeutics
VERA
|
+$39.2M |
| 5 |
Nike
NKE
|
+$36.2M |
Sector Composition
| 1 | Healthcare | 96.95% |
| 2 | Technology | 1.18% |
| 3 | Communication Services | 0.76% |
| 4 | Real Estate | 0.1% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aurinia Pharmaceuticals
AUPH
$1.87B
| $181M | 8.93% |
11,329,500
|
|
||
2
Galapagos
GLPG
$2.16B
| $128M | 6.33% |
3,921,219
-229,975
|
|
||
3
PTC Therapeutics
PTCT
$5.17B
| $114M | 5.63% |
1,500,000
|
|
||
4
Celcuity
CELC
$5.35B
| $105M | 5.17% |
1,050,000
-100,000
|
|
||
5
Mirum Pharmaceuticals
MIRM
$5.22B
| $97.6M | 4.82% |
1,236,027
|
|
||
6
Tarsus Pharmaceuticals
TARS
$3.12B
| $97.3M | 4.81% |
1,188,624
-1,266,173
|
|
||
7
Kiniksa Pharmaceuticals
KNSA
$3.56B
| $93.2M | 4.6% |
2,259,889
-68,720
|
|
||
8
Immunocore
IMCR
$1.65B
| $91.2M | 4.51% |
2,628,538
+322,930
|
|
||
9
Compass Therapeutics
CMPX
$964M
| $90.2M | 4.45% |
16,790,809
-21,154
|
|
||
10
KalVista Pharmaceuticals
KALV
$816M
| $73.9M | 3.65% |
4,573,530
-468,268
|
|
||
|
RNAM
11
DELISTED
Avidity Biosciences
RNAM
| $64.9M | 3.21% |
+900,000
|
|
||
12
AnaptysBio
ANAB
$1.54B
| $64.6M | 3.19% |
1,332,087
-1,552
|
|
||
13
Spyre Therapeutics
SYRE
$3.13B
| $62M | 3.06% |
1,892,200
-1,307,800
|
|
||
14
Viridian Therapeutics
VRDN
$2.67B
| $55.8M | 2.76% |
1,792,626
-1,050,299
|
|
||
15
Capricor Therapeutics
CAPR
$1.48B
| $49.1M | 2.42% |
+1,700,000
|
|
||
|
16
BioNTech
BNTX
$25.4B
| $44.7M | 2.21% |
470,000
+200,000
|
|
||
|
17
ANI Pharmaceuticals
ANIP
$1.66B
| $38M | 1.88% |
481,437
+163,937
|
|
||
18
Vertex Pharmaceuticals
VRTX
$115B
| $36.3M | 1.79% |
80,000
|
|
||
19
Nuvation Bio
NUVB
$1.58B
| $34.6M | 1.71% |
3,857,457
-342,543
|
|
||
20
Travere Therapeutics
TVTX
$2.48B
| $26.7M | 1.32% |
700,000
|
|
||
21
Ventyx Biosciences
VTYX
| $25.4M | 1.26% |
2,814,000
-286,000
|
|
||
22
NVIDIA
NVDA
$4.4T
| $23.8M | 1.18% |
127,788
-2,721
|
|
||
23
Precigen
PGEN
$1.16B
| $23.5M | 1.16% |
5,617,500
-6,782,500
|
|
||
24
State Street SPDR S&P 500 ETF Trust
SPY
$683B
| $20.5M | 1.01% |
+30,000
|
|
||
25
Moderna
MRNA
$20.5B
| $20.4M | 1.01% |
692,820
+387,520
|
|